These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 24284745)

  • 61. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs.
    Machitani M; Sakurai F; Katayama K; Tachibana M; Suzuki T; Matsui H; Yamaguchi T; Mizuguchi H
    Virus Res; 2013 Dec; 178(2):357-63. PubMed ID: 24055658
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
    Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
    Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer.
    Ellermeier J; Wei J; Duewell P; Hoves S; Stieg MR; Adunka T; Noerenberg D; Anders HJ; Mayr D; Poeck H; Hartmann G; Endres S; Schnurr M
    Cancer Res; 2013 Mar; 73(6):1709-20. PubMed ID: 23338611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Murine tyrosinase expressed by a T7 vector in bone marrow-derived dendritic progenitors effectively prevents and eradicates melanoma tumors in mice.
    Li J; Holmes LM; Franek KJ; Wagner TE; Wei Y
    Cancer Gene Ther; 2000 Nov; 7(11):1448-55. PubMed ID: 11129287
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway.
    Zhao JJ; Hao S; Wang LL; Hu CY; Zhang S; Guo LJ; Zhang G; Gao B; Jiang Y; Tian WG; Luo DL
    Oncotarget; 2016 Sep; 7(36):57903-57918. PubMed ID: 27507052
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Construction of eukaryotic expression vector of short hairpin RNA for transforming growth factor-beta1].
    Wang J; Wu JZ; Guo FP; Zhu XL; Wen DS
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2006 Apr; 24(2):113-6. PubMed ID: 16704085
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
    Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
    J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy.
    Jiang J; Zhang Y; Peng K; Wang Q; Hong X; Li H; Fan G; Zhang Z; Gong T; Sun X
    Acta Biomater; 2017 Oct; 61():114-123. PubMed ID: 28483693
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhanced FHL2 and TGF-β1 Expression Is Associated With Invasive Growth and Poor Survival in Malignant Melanomas.
    Westphal P; Mauch C; Florin A; Czerwitzki J; Olligschläger N; Wodtke C; Schüle R; Büttner R; Friedrichs N
    Am J Clin Pathol; 2015 Feb; 143(2):248-56; quiz 307. PubMed ID: 25596251
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gene silencing of beta-catenin in melanoma cells retards their growth but promotes the formation of pulmonary metastasis in mice.
    Takahashi Y; Nishikawa M; Suehara T; Takiguchi N; Takakura Y
    Int J Cancer; 2008 Nov; 123(10):2315-20. PubMed ID: 18729199
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Parathyroid hormone-related protein: potential therapeutic target for melanoma invasion and metastasis.
    Huang DC; Yang XF; Ochietti B; Fadhil I; Camirand A; Kremer R
    Endocrinology; 2014 Oct; 155(10):3739-49. PubMed ID: 25051432
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A recombinant adeno-associated virus expressing secretory TGF-β type Ⅱ receptor inhibits triple-negative murine breast cancer 4T1 cell proliferation and lung metastasis in mice].
    Cui Z; Ma C; Wang Q; Chen J; Yan Z; Yang J; Lü Y; Cao C
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):818-826. PubMed ID: 38862439
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice.
    Wang X; Wang M; Amarzguioui M; Liu F; Fodstad Ø; Prydz H
    Int J Cancer; 2004 Dec; 112(6):994-1002. PubMed ID: 15386437
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
    Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
    J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice.
    Warshamana GS; Pociask DA; Fisher KJ; Liu JY; Sime PJ; Brody AR
    Int J Exp Pathol; 2002 Aug; 83(4):183-201. PubMed ID: 12485463
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity.
    Liu XY; Tang QS; Chen HC; Jiang XL; Fang H
    Int J Biol Sci; 2013; 9(6):564-77. PubMed ID: 23847439
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism.
    Canè S; Van Snick J; Uyttenhove C; Pilotte L; Van den Eynde BJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637600
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine.
    Wang X; Zhao F; He X; Wang J; Zhang Y; Zhang H; Ni Y; Sun J; Wang X; Dou J
    Oncotarget; 2015 May; 6(14):12493-504. PubMed ID: 25895132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.